SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Regeneron Pharmaceuticals
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
3559 104 0 REGN
Emcee:  Patrick Slevin Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2557At this point earning is irrelevant. Everyone expect positive growth for next feMiljenko Zuanic-11/2/2018
2556What are your thoughts on SP after earnings next weekFelix B-11/2/2018
25552018 ASH, bi-specific BCMAxCD3 , <Collectively, these data demonstrate the pMiljenko Zuanic-11/1/2018
2554Few tid-bits from Sanofi 3Q cc: -Dupi US sale was $220m, ex-US $42m, total $262mMiljenko Zuanic-11/1/2018
2553Is IL33 that hard target that need to be addressed by iv/Ab's? From GSK: cliMiljenko Zuanic-11/1/2018
2552Roche’s phase-2 Faricimab AMD data at AAO: investorshub.advfn.comDewDiligence_on_SI-10/27/2018
2551Model price projections per CMS: cms.gov <? CMS would phase-in the Target PriMiljenko Zuanic-10/25/2018
2550<When the prefilled syringe is available, the question is: What % of Eylea MeMiljenko Zuanic-10/25/2018
2549Model: hhs.gov <Here is how the model will work: Today’s system: Medicare setMiljenko Zuanic-10/25/2018
2548When the prefilled syringe is available, the question is: What % of Eylea MedicaDewDiligence_on_SI-10/25/2018
2547Eylea price in Canada, (and ex-US): pmprb-cepmb.gc.ca IF US medicare PartB priMiljenko Zuanic-10/25/2018
2546<Go TRUMP, Go!> twitter.com Definitely, he attacked Eylea several time. Miljenko Zuanic-10/25/2018
2545New hick-up on regulatory front, this time Eylea CRL (small effect on company peMiljenko Zuanic-10/25/2018
2544No they don't. But, some at REGN think that they are cool!Miljenko Zuanic-10/20/2018
2543By and large, marketing people don't like loading doses.DewDiligence_on_SI-10/19/2018
2542Thanks for your thoughts; they are worth keeping in mind while watching PRS-060 tuck-10/19/2018
2541RE: Dupi I do not understand why did they applied "loading" dose, whenMiljenko Zuanic-10/19/2018
2540Rx info: regeneron.com Dupi label for asthma is favorable, sticky point was 300Miljenko Zuanic-10/19/2018
2539Halt lifted, and stock appears to be up about 7 points. Not totally priced in, tuck-10/19/2018
2538Am seeing chatter that REGN is halted post market. And this is a Friday. Oh, atuck-10/19/2018
2537Some idea.... researchgate.netMiljenko Zuanic-10/17/2018
2536<Do you have handy the YoY growth in the incidence of US and worldwide wet AMMiljenko Zuanic-10/17/2018
2535Do you have handy the YoY growth in the incidence of US and worldwide wet AMD? TDewDiligence_on_SI-10/17/2018
25343Q Eylea-sale predictions.... Roche US-Lucentis 3Q sale ($417m) decline relatiMiljenko Zuanic-10/17/2018
2533It is co-morbidity with allergic asthma.... point is that it may be preferentialMiljenko Zuanic-10/17/2018
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News